The U.S. health regulator has sent a warning letter to Cardinal Health after an inspection of its facility in Illinois showed that the company was marketing unapproved devices.
The U.S. Food and Drug Administration (FDA) during its inspection determined that Cardinal was an importer of syringes sold under the Monoject brand.
The agency, in its letter sent to Cardinal on…

#cardinalhealth#illinois#fda#cardinal#monoject